Suppr超能文献

豚鼠气管中合成速激肽激动剂对上皮和平滑肌NK1受体的差异性激活

Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.

作者信息

Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P

机构信息

Department of Experimental and Clinical Medicine, Pharmacology Unit, University of Ferrara, Italy.

出版信息

Br J Pharmacol. 1997 Jun;121(4):773-81. doi: 10.1038/sj.bjp.0701188.

Abstract
  1. The presence of tachykinin NK1 receptors have been shown in the epithelium and smooth muscle of guinea-pig airways. Previous data showed that substance P (SP), and the NK1 receptor agonist, [Sar9, Met (O2)11]-SP, relax guinea-pig tracheal tube preparations by stimulation of epithelial NK1 receptors and via nitric oxide (NO) release. However, the selective tachykinin NK1 receptor agonist, septide, was unable to produce this effect. The aim of the present study was to investigate the ability of a series of SP analogues to stimulate NK1 receptors of guinea-pig airway epithelium. 2. Isometric tension was recorded in isolated tracheal tube preparations in which compounds were administered intraluminally in the presence of phosphoramidon, indomethacin (both 1 microM) and the tachykinin NK2 receptor antagonist, SR 48,968 ((S)-N-methyl N-(4-acetyl-amino-4-phenylpiperidino)-2-(3,4-dichlorophenyl)butyl)benzam ide) (0.1 microM). Cumulative concentration-response curves were obtained in preparations under resting tone or in preparations precontracted with acetylcholine (ACh, 10 microM). 3. Contractile responses to low concentrations (0.1-10 nM) of substance P (SP) and the selective agonist of NK1 receptors, [Pro9]-SP. in non precontracted tracheae were higher in preparations pretreated with the NO-synthase inhibitor, NG-monomethyl L-arginine (L-NMMA, 100 microM) than in preparations pretreated with its inactive enantiomer D-NMMA (100 microM). Tracheal tube preparations precontracted with ACh and pretreated with D-NMMA were relaxed by low concentrations of SP and [Pro9]-SP (0.1-10 nM). In contrast, after pretreatment with L-NMMA, SP and [Pro9]-SP contracted tracheae at all the concentrations tested. 4. Concentration-response curves to the NK1 receptor agonists, SP methyl ester, [Apa9-10]-SP and [pGlu6] SP (6-11) obtained in non-precontracted tracheae were similar in the presence of either D-NMMA or L-NMMA. SP methyl ester, [Apa9-10]-SP and [pGlu6] SP (6-11) did not produce any relaxation, but instead, cause contractions in tracheal tube preparations precontracted with ACh and pretreated with D-NMMA. Concentration-response curves produced by all these agonists were similar in preparations precontracted with ACh and pretreated with L-NMMA or D-NMMA. 5. In guinea-pig tracheal tube preparations two groups of NK1 receptor agonists can be distinguished: one group, including [Pro9]-SP, stimulator epithelial NK1 receptors, the other group, including SP methyl ester, [Apa9-10]-SP and [pGlu6] SP (6-11), does not. One possible explanation for these findings and for the existence of compounds with a peculiar 'septide-like' pharmacological profile in the guinea-pig trachea could be the recently proposed phenomenon referred to as 'agonist-directed receptor trafficking'.
摘要
  1. 速激肽NK1受体已在豚鼠气道的上皮和平滑肌中被证实存在。先前的数据表明,P物质(SP)以及NK1受体激动剂[Sar9,Met(O2)11]-SP,通过刺激上皮NK1受体并经由一氧化氮(NO)释放,使豚鼠气管制备物舒张。然而,选择性速激肽NK1受体激动剂septide无法产生这种效应。本研究的目的是调查一系列SP类似物刺激豚鼠气道上皮NK1受体的能力。2. 在离体气管制备物中记录等长张力,其中化合物在磷酰胺、吲哚美辛(均为1微摩尔)和速激肽NK2受体拮抗剂SR 48,968((S)-N-甲基-N-(4-乙酰氨基-4-苯基哌啶基)-2-(3,4-二氯苯基)丁基)苯甲酰胺)(0.1微摩尔)存在的情况下经腔内给药。在静息张力下的制备物或用乙酰胆碱(ACh,10微摩尔)预收缩的制备物中获得累积浓度-反应曲线。3. 在未预收缩的气管中,对低浓度(0.1 - 10纳摩尔)的P物质(SP)和NK1受体选择性激动剂[Pro9]-SP的收缩反应,在用一氧化氮合酶抑制剂NG-单甲基-L-精氨酸(L-NMMA,100微摩尔)预处理的制备物中高于用其无活性对映体D-NMMA(100微摩尔)预处理的制备物。用D-NMMA预处理并用ACh预收缩的气管制备物,在低浓度的SP和[Pro9]-SP(0.1 - 10纳摩尔)作用下舒张。相反,在用L-NMMA预处理后,SP和[Pro9]-SP在所有测试浓度下均使气管收缩。4. 在未预收缩的气管中获得的对NK1受体激动剂SP甲酯、[Apa9 - 10]-SP和[pGlu6] SP(6 - 11)的浓度-反应曲线,在D-NMMA或L-NMMA存在时相似。SP甲酯、[Apa9 - 10]-SP和[pGlu6] SP(6 - 11)未产生任何舒张作用,反而在用D-NMMA预处理并用ACh预收缩的气管制备物中引起收缩。所有这些激动剂产生的浓度-反应曲线在用ACh预收缩且用L-NMMA或D-NMMA预处理的制备物中相似。5. 在豚鼠气管制备物中,可以区分出两组NK1受体激动剂:一组包括[Pro9]-SP,可刺激上皮NK1受体;另一组包括SP甲酯、[Apa9 - 10]-SP和[pGlu6] SP(6 - 11),则不能。对这些发现以及豚鼠气管中存在具有特殊“肽样”药理学特征的化合物的一种可能解释可能是最近提出的被称为“激动剂导向的受体转运”的现象。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验